Dr. Jacob Patrick Ossoff, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 15 Exchange Dr, Lugoff, SC 29078 Phone: 803-408-3277 |
Stephanie H Tetterton, PA Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 15 Exchange Dr, Lugoff, SC 29078 Phone: 803-408-3277 Fax: 803-408-3282 |
Dr. Joseph Anthony Sciarrino, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 15 Exchange Dr, Lugoff, SC 29078 Phone: 803-424-2207 Fax: 803-408-3282 |
Dr. David Macy Vidrine, M.D. Otolaryngology - Pediatric Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 15 Exchange Dr, Lugoff, SC 29078 Phone: 803-408-3277 Fax: 803-408-3282 |
Dr. Valerie Alison Fritsch, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 15 Exchange Dr, Lugoff, SC 29078 Phone: 803-408-3277 Fax: 803-408-3299 |
Dr. Robert Puchalski, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 15 Exchange Dr, Lugoff, SC 29078 Phone: 803-408-3277 Fax: 803-408-3299 |
Dr. Brian Boone, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 15 Exchange Dr, Lugoff, SC 29078 Phone: 803-408-3277 Fax: 803-408-3299 |
Dr. Janaki Lakshmi Emani, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 15 Exchange Dr, Lugoff, SC 29078 Phone: 803-408-3277 Fax: 803-408-3282 |
News Archive
Direct-to-consumer (DTC) genetic tests available from retailers and the Internet let people learn about their genomes without going to a doctor, but they raise the question of who is responsible for oversight and regulation of these tests. Critics worry about safety risks if consumers base important lifestyle or medical decisions on inaccurate or misunderstood test results.
Osteoporosis is the most common age-related bone disease which affects hundreds of millions of individuals worldwide. It is estimated that one in three women and one in five men aged over 50 suffer from osteoporotic bone fractures.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that the United Kingdom's National Institute for Health and Care Excellence issued draft guidance recommending ILUVIEN for the treatment of pseudophakic patients (those who have undergone prior cataract surgery) with chronic diabetic macular edema considered insufficiently responsive to available therapies.
The greater the volume of blood removed from the brain via minimally invasive surgery after a cerebral hemorrhage the greater the odds of better functional recovery, according to late breaking science presented at the American Stroke Association's International Stroke Conference 2019, a world premier meeting for researchers and clinicians dedicated to the science and treatment of cerebrovascular disease.
› Verified 6 days ago